Ya‐Qun Zhou

3.5k total citations · 1 hit paper
79 papers, 2.6k citations indexed

About

Ya‐Qun Zhou is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ya‐Qun Zhou has authored 79 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Physiology, 28 papers in Molecular Biology and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ya‐Qun Zhou's work include Pain Mechanisms and Treatments (45 papers), Pharmacological Effects of Natural Compounds (13 papers) and Neuropeptides and Animal Physiology (8 papers). Ya‐Qun Zhou is often cited by papers focused on Pain Mechanisms and Treatments (45 papers), Pharmacological Effects of Natural Compounds (13 papers) and Neuropeptides and Animal Physiology (8 papers). Ya‐Qun Zhou collaborates with scholars based in China, United States and United Kingdom. Ya‐Qun Zhou's co-authors include Dawei Ye, Yuke Tian, Dai-Qiang Liu, Shuping Chen, Jia Sun, Wei Mei, Long-Qing Zhang, Haowen Zhang, Shao‐Jie Gao and Zheng Liu and has published in prestigious journals such as Nature Communications, Journal of Neurophysiology and Brain Research.

In The Last Decade

Ya‐Qun Zhou

77 papers receiving 2.6k citations

Hit Papers

Interleukin-6: an emerging regulator of pathological pain 2016 2026 2019 2022 2016 100 200 300

Peers

Ya‐Qun Zhou
Yuke Tian China
Gu Seob Roh South Korea
Liang Hu China
Wen Xiao China
Corbin Bachmeier United States
Yuke Tian China
Ya‐Qun Zhou
Citations per year, relative to Ya‐Qun Zhou Ya‐Qun Zhou (= 1×) peers Yuke Tian

Countries citing papers authored by Ya‐Qun Zhou

Since Specialization
Citations

This map shows the geographic impact of Ya‐Qun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Qun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Qun Zhou more than expected).

Fields of papers citing papers by Ya‐Qun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Qun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Qun Zhou. The network helps show where Ya‐Qun Zhou may publish in the future.

Co-authorship network of co-authors of Ya‐Qun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Qun Zhou. A scholar is included among the top collaborators of Ya‐Qun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Qun Zhou. Ya‐Qun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Xinyi, Wenlu Song, Jiayi Wu, et al.. (2025). The role of PGC-1α in brain injury: mechanisms and therapeutic potential. 1 indexed citations
2.
Hu, Junjie, Ya‐Qun Zhou, Zhiheng Liu, et al.. (2024). DNA damage induced PARP‐1 overactivation confers paclitaxel‐induced neuropathic pain by regulating mitochondrial oxidative metabolism. CNS Neuroscience & Therapeutics. 30(9). e70012–e70012. 3 indexed citations
3.
4.
Liu, Dai-Qiang, et al.. (2024). Targeting TRPM channels for cerebral ischemia–reperfusion injury. Trends in Pharmacological Sciences. 45(10). 862–867. 8 indexed citations
5.
Chen, Nan, et al.. (2024). PGC‐1α activation ameliorates cancer-induced bone pain via inhibiting apoptosis of GABAergic interneurons. Biochemical Pharmacology. 222. 116053–116053. 4 indexed citations
6.
Li, Danyang, Shao‐Jie Gao, Jia Sun, et al.. (2022). Notch signaling activation contributes to paclitaxel-induced neuropathic pain via activation of A1 astrocytes. European Journal of Pharmacology. 928. 175130–175130. 14 indexed citations
7.
Sun, Jia, Fan‐He Song, Jiayi Wu, et al.. (2022). Sestrin2 overexpression attenuates osteoarthritis pain via induction of AMPK/PGC-1α-mediated mitochondrial biogenesis and suppression of neuroinflammation. Brain Behavior and Immunity. 102. 53–70. 76 indexed citations
8.
Zhang, Long-Qing, Shao‐Jie Gao, Jia Sun, et al.. (2022). DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation. Journal of Neuroinflammation. 19(1). 129–129. 83 indexed citations
9.
Huang, Jian, Luxin Wang, Yunli Shen, et al.. (2022). CDC-like kinase 4 deficiency contributes to pathological cardiac hypertrophy by modulating NEXN phosphorylation. Nature Communications. 13(1). 4433–4433. 12 indexed citations
10.
Zhou, Ya‐Qun, Wei Mei, Xuebi Tian, et al.. (2021). The therapeutic potential of Nrf2 inducers in chronic pain: Evidence from preclinical studies. Pharmacology & Therapeutics. 225. 107846–107846. 53 indexed citations
11.
Zhou, Ya‐Qun, Xuebi Tian, Yuke Tian, et al.. (2021). Wnt signaling: A prospective therapeutic target for chronic pain. Pharmacology & Therapeutics. 231. 107984–107984. 22 indexed citations
12.
Zhou, Ya‐Qun, Dai-Qiang Liu, Shuping Chen, et al.. (2020). PPARγ activation mitigates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of Nrf2/HO-1 signaling pathway. Biomedicine & Pharmacotherapy. 129. 110356–110356. 42 indexed citations
13.
Chen, Shuping, Ya‐Qun Zhou, Xiaomei Wang, et al.. (2019). Pharmacological inhibition of the NLRP3 inflammasome as a potential target for cancer-induced bone pain. Pharmacological Research. 147. 104339–104339. 59 indexed citations
14.
Sun, Jia, Ya‐Qun Zhou, Shuping Chen, et al.. (2019). The endocannabinoid system: Novel targets for treating cancer induced bone pain. Biomedicine & Pharmacotherapy. 120. 109504–109504. 17 indexed citations
15.
Zhou, Ya‐Qun, Dai-Qiang Liu, Shuping Chen, et al.. (2018). Minocycline as a promising therapeutic strategy for chronic pain. Pharmacological Research. 134. 305–310. 61 indexed citations
16.
Zhou, Ya‐Qun, Dai-Qiang Liu, Shuping Chen, et al.. (2017). Reactive oxygen species scavengers ameliorate mechanical allodynia in a rat model of cancer-induced bone pain. Redox Biology. 14. 391–397. 76 indexed citations
17.
Shi, Dai, Ya‐Qun Zhou, Hua Zheng, et al.. (2016). MHC-I promotes apoptosis of GABAergic interneurons in the spinal dorsal horn and contributes to cancer induced bone pain. Experimental Neurology. 286. 12–20. 38 indexed citations
18.
Song, Zhenpeng, Bingrui Xiong, Hua Zheng, et al.. (2016). STAT1 as a downstream mediator of ERK signaling contributes to bone cancer pain by regulating MHC II expression in spinal microglia. Brain Behavior and Immunity. 60. 161–173. 37 indexed citations
19.
Zhu, Mingxin, Mingwu Li, Ya‐Qun Zhou, et al.. (2016). Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo. British Journal of Anaesthesia. 116(6). 870–877. 48 indexed citations
20.
Zhou, Ya‐Qun, et al.. (2015). Chemokines and Their Receptors: Potential Therapeutic Targets for Bone Cancer Pain. Current Pharmaceutical Design. 21(34). 5029–5033. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026